StMichaelTwits
$ANVS
Dr. Maria Maccecchini, Founder, President, and CEO of Annovis Bio (NYSE: ANVS), is scheduled to speak today, from 11:25 a.m. to 11:55 a.m. ET (8:25 a.m. to 8:55 a.m. PT).
Presentation Details
• Event. Pharma Partnering Summit 2026 in Boston, MA.
• Session Title. "Restoring Proteostasis in Alzheimer's and Parkinson's Diseases with Buntanetap, a Translational Inhibitor of Neurotoxic Proteins".
• Focus. She will review Annovis Bio's clinical progress, upcoming milestones, and lead drug candidate buntanetap, alongside one-on-one meetings with biotech and pharmaceutical industry representatives.
Note: Annovis Bio also has a separate oral presentation scheduled today at 3:52 p.m. ET at the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston covering the clinical trial design and baseline characteristics of buntanetap's pivotal early Alzheimer's study.
20

:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault35.jpg)